Atlas Trials

A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms

Clinical trial NCT02163226 · COMPLETED

Trial details

NCT number
NCT02163226
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Bone Metastases
Start date
2014-08-06
Primary completion
2020-09-02
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.